ANIP
Published on 05/08/2026 at 11:38 am EDT
ANI Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was USD 237.46 million compared to USD 197.12 million a year ago. Net income was USD 29.49 million compared to USD 15.68 million a year ago.
Basic earnings per share from continuing operations was USD 1.31 compared to USD 0.7 a year ago. Diluted earnings per share from continuing operations was USD 1.28 compared to USD 0.69 a year ago.